1.
Azem A, Abuhelwa Z, Iqbal U, Ali NA, Kareem SS, Padron E, Chan O, Kuykendall A, Xie Z, Walker A, Shallis R, Lancet J, Komrokji R, Sallman DA. Frontline isocitrate dehydrogenase inhibitor therapy in isocitrate dehydrogenase-mutated myelodysplastic neoplasms. Haematologica [Internet]. 2026Nov.5 [cited 2026Nov.9];. Available from: https://haematologica.org/article/view/14527